This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardam, M. A.
Right arrow Articles by Miller, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardam, M. A.
Right arrow Articles by Miller, M. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 1998, p. 833-834, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Optochin Revisited: Defining the Optimal Type of Blood Agar for Presumptive Identification of Streptococcus pneumoniae

M. A. Gardam and M. A. Miller*

Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Canada

Received 10 July 1997/Returned for modification 14 October 1997/Accepted 4 December 1997

To determine the optimal media for optochin susceptibility testing of Streptococcus pneumoniae, we measured inhibition zones for 72 S. pneumoniae and 22 Streptococcus viridans isolates on three blood-containing media. Because 15.3, 0, and 22.2% of S. pneumoniae organisms were misidentified on Columbia agar, Trypticase soy agar (TSA), and Mueller-Hinton agar, respectively, each containing sheep blood, we recommend that TSA-sheep blood agar be used.


* Corresponding author. Mailing address: Department of Microbiology, SMBD-Jewish General Hospital, 3755 Cote-Ste-Catherine, Montreal, QC, Canada, H3T 1E2. Phone: (514) 340-8294. Fax: (514) 340-7546. E-mail: mmiller{at}lab.jgh.mcgill.ca.


Journal of Clinical Microbiology, March 1998, p. 833-834, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Fukushima, K. Y., Hirakata, Y., Sugahara, K., Yanagihara, K., Kondo, A., Kohno, S., Kamihira, S. (2006). Rapid Screening of Topoisomerase Gene Mutations by a Novel Melting Curve Analysis Method for Early Warning of Fluoroquinolone-Resistant Streptococcus pneumoniae Emergence. J. Clin. Microbiol. 44: 4553-4558 [Abstract] [Full Text]  
  • Reinert, R. R., Jacobs, M. R., Appelbaum, P. C., Bajaksouzian, S., Cordeiro, S., van der Linden, M., Al-Lahham, A. (2005). Relationship between the Original Multiply Resistant South African Isolates of Streptococcus pneumoniae from 1977 to 1978 and Contemporary International Resistant Clones. J. Clin. Microbiol. 43: 6035-6041 [Abstract] [Full Text]  
  • Reinert, R. R., Reinert, S., van der Linden, M., Cil, M. Y., Al-Lahham, A., Appelbaum, P. (2005). Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003. Antimicrob. Agents Chemother. 49: 2903-2913 [Abstract] [Full Text]  
  • Arbique, J. C., Poyart, C., Trieu-Cuot, P., Quesne, G., Carvalho, M. d. G. S., Steigerwalt, A. G., Morey, R. E., Jackson, D., Davidson, R. J., Facklam, R. R. (2004). Accuracy of Phenotypic and Genotypic Testing for Identification of Streptococcus pneumoniae and Description of Streptococcus pseudopneumoniae sp. nov.. J. Clin. Microbiol. 42: 4686-4696 [Abstract] [Full Text]  
  • Kellogg, J. A., Bankert, D. A., Elder, C. J., Gibbs, J. L., Smith, M. C. (2001). Identification of Streptococcus pneumoniae Revisited. J. Clin. Microbiol. 39: 3373-3375 [Abstract] [Full Text]  
  • Cima-Cabal, M. D., Vázquez, F., de los Toyos, J. R., Méndez, F. J. (1999). Rapid and Reliable Identification of Streptococcus pneumoniae Isolates by Pneumolysin-Mediated Agglutination. J. Clin. Microbiol. 37: 1964-1966 [Abstract] [Full Text]